Literature DB >> 8108756

HIV seroprevalence and reasons for refusing and accepting HIV testing.

J L Jones1, P Hutto, P Meyer, H Dowda, W B Gamble, R A Gunn.   

Abstract

BACKGROUND AND OBJECTIVES: We sought to evaluate the HIV seropositivity of patients who refused or accepted human immunodeficiency virus (HIV) testing in a South Carolina sexually transmitted diseases (STD) clinic, and the patients' reasons for refusing or accepting testing. STUDY
DESIGN: A serologic and self-administered survey done Jan. 9 through June 1, 1989. For those who refused HIV testing, a routine syphilis serology sample was tested blindly for HIV.
RESULTS: Of 1,929 patients in the study, 398 (21%) refused HIV testing. HIV test refusers were 2.2 times more likely to be HIV antibody positive than HIV test acceptors (3.0% versus 1.4%, prevalence ratio = 2.2, CI95 1.1-4.4), with this difference mainly occurring among males. Seven of eight patients reporting that they refused testing because they were HIV positive were found to be HIV negative. The principal reason indicated for test refusal was not feeling at risk for HIV infection. The principal reasons indicated for test acceptance were wanting to know the results for their own health status and wishing to prevent spread of the virus to partners.
CONCLUSION: We conclude that: (1) a higher seropositivity exists among HIV test refusers than acceptors; (2) patient reporting HIV seropositivity should be viewed with caution; (3) many STD patients deny their risk for HIV; and (4) STD patients are concerned about transmission of HIV to their partners.

Entities:  

Mesh:

Year:  1993        PMID: 8108756

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  10 in total

1.  Uptake of HIV testing in a genitourinary medicine clinic is affected by individual doctors.

Authors:  M Griffiths; H Stockdale; A J Winter; M Huengsberg
Journal:  Sex Transm Infect       Date:  2001-04       Impact factor: 3.519

2.  Risk, reasons for refusal, and impact of counseling on consent among ED patients declining HIV screening.

Authors:  Nitin D Ubhayakar; Christopher J Lindsell; Dana L Raab; Andrew H Ruffner; Alexander T Trott; Carl J Fichtenbaum; Michael S Lyons
Journal:  Am J Emerg Med       Date:  2010-03-25       Impact factor: 2.469

3.  Barriers to universal prenatal HIV testing in 4 US locations in 1997.

Authors:  R A Royce; E B Walter; M I Fernandez; T E Wilson; J R Ickovics; R J Simonds
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

4.  Routine opt-out HIV testing in an urban community health center.

Authors:  Chinazo O Cunningham; Bethany Doran; Joseph DeLuca; Robert Dyksterhouse; Ramin Asgary; Galit Sacajiu
Journal:  AIDS Patient Care STDS       Date:  2009-08       Impact factor: 5.078

5.  Factors influencing consent to HIV testing among wives of heavy drinkers in an urban slum in India.

Authors:  Veena A Satyanarayana; Prabha S Chandra; Krishna Vaddiparti; Vivek Benegal; Linda B Cottler
Journal:  AIDS Care       Date:  2009-05

6.  Methods for estimating HIV prevalence: A comparison of extrapolation from surveys on infection rate and risk behaviour with back-calculation for the Netherlands.

Authors:  H Houweling; S H Heisterkamp; L G Wiessing; R A Coutinho; J K van Wijngaarden; H J Jager
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

7.  Continuing transmission of sexually transmitted diseases among patients infected with HIV-1 attending genitourinary medicine clinics in England and Wales.

Authors:  M A Catchpole; D E Mercey; A Nicoll; P A Rogers; I Simms; J Newham; A Mahoney; J V Parry; C Joyce; O N Gill
Journal:  BMJ       Date:  1996-03-02

8.  Prevalence of HIV infection among inpatients and outpatients in Department of Veterans Affairs health care systems: implications for screening programs for HIV.

Authors:  Douglas K Owens; Vandana Sundaram; Laura C Lazzeroni; Lena R Douglass; Gillian D Sanders; Kathie Taylor; Ronald VanGroningen; Vera M Shadle; Valerie C McWhorter; Teodora Agoncillo; Noreen Haren; Jill Nyland; Patricia Tempio; Walid Khayr; Dennis J Dietzen; Peter Jensen; Michael S Simberkoff; Samuel A Bozzette; Mark Holodniy
Journal:  Am J Public Health       Date:  2007-10-30       Impact factor: 9.308

9.  Tuberculosis-HIV co-infection in Kiev City, Ukraine.

Authors:  Marieke J van der Werf; Olga B Yegorova; Nelly Chentsova; Yuriy Chechulin; Epco Hasker; Vasyl I Petrenko; Jaap Veen; Leonid V Turchenko
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

10.  Implications of the HIV testing protocol for refusal bias in seroprevalence surveys.

Authors:  Georges Reniers; Tekebash Araya; Yemane Berhane; Gail Davey; Eduard J Sanders
Journal:  BMC Public Health       Date:  2009-05-28       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.